[Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
D000328:Adult; D000368:Aged; D000983:Antipyrine / Q000378:metabolism* / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006505:Hepatitis / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000378:metabolism; D008107:Liver Diseases / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D014532:Uridine Diphosphate Glucose / Q000494:pharmacology*; D014539:Uridine Diphosphate Sugars / Q000494:pharmacology*
D014539:Uridine Diphosphate Sugars; D000983:Antipyrine; D014532:Uridine Diphosphate Glucose
L'attività farmaco-metabolica nelle epatopatie croniche: influenza del trattamento con UDPG.